salicylidenecurcumin

attenuates cataract formation; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Abraham, Annie: 1 article (12/2012)
2.	Devi Rukhmini, Sudha: 1 article (12/2012)
3.	Radha, Asha: 1 article (12/2012)
4.	Sakunthala, Priya Rajan: 1 article (12/2012)
5.	Sasikala, Vilasini: 1 article (12/2012)
6.	Sreedharan, Balachandran: 1 article (12/2012)
7.	Velayudhan, Mohanan Puzhavoorparambil: 1 article (12/2012)

1.	Cataract (Cataracts) 12/01/2012 - "In this study, curcumin derivatives salicylidenecurcumin (CD1) and benzalidenecurcumin (CD2)] were prepared, and their biological activity was compared in in vitro selenite-induced cataract model. "